ArticleClinical case reports2026
Visceral Leishmaniasis in Somalia: Diagnosis and Management of a Classic Case in a Resource-Limited Endemic Setting.
Article in Clinical case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Visceral Leishmaniasis (VL), a severe systemic neglected tropical disease (NTD) caused by Leishmania donovani complex protozoa, poses a significant public health threat, particularly in East Africa, where it is fatal if untreated. Somalia is known to be endemic, but the true burden and programmatic challenges are poorly documented due to long-standing conflict, population displacement, and a fragmented, resource-constrained health system. We report the case of a 40-year-old male farmer from Borama, Awdal region (Somaliland), presenting with a 20-day history of intermittent high-grade fever, chills, progressive weakness, anorexia, and vomiting. Physical examination revealed marked hepatosplenomegaly and pallor. Laboratory investigations showed moderate anemia (Hemoglobin 9.4 g/dL), thrombocytopenia (114,000/μL), and a highly elevated ESR (50 mm/h). Mild hyperbilirubinemia was noted, likely secondary to hemolysis. Tests for malaria, tuberculosis, and enteric fever were negative. Definitive parasitological confirmation was not feasible due to local resource limitations. A rapid diagnostic test (RDT) for VL based on rK39 antigen-Kalazar Detect (Human) Rapid Test-was positive. Ultrasound confirmed significant hepato-splenomegaly. Based on the clinical presentation, positive rK39 RDT, and exclusion of other etiologies, a diagnosis of Visceral Leishmaniasis was established. The patient was treated according to WHO regional guidelines with Sodium Stibogluconate (SSG, 20 mg/kg/day) and Paromomycin (PM, 15 mg/kg/day) for 17 days. The patient tolerated treatment well; the fever resolved within five days. At one-week post-therapy follow-up, he showed significant clinical improvement. This case highlights the classic presentation of VL in a fragile setting and underscores the critical role of RDTs where parasitological confirmation is unavailable. It demonstrates the feasibility of the WHO-recommended SSG+PM combination therapy despite systemic challenges.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.